The Investor
02 Sep 2025, 20:36
Evernorth Health Services (The Cigna Group) Invests $3.5B in Shields Health Solutions
BLOOMFIELD, Conn., Sept. 2, 2025 — Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI), announced a $3.5 billion preferred stock investment in Shields Health Solutions, a leading specialty pharmacy management company.
The investment coincides with Shields’ transition to a private standalone company, following its acquisition by Sycamore Partners from Walgreens Boots Alliance, which closed on August 28, 2025.
Evernorth said the investment supports the growing market for specialty medicine and aligns with its strategy to enhance care for people with complex and chronic conditions. The deal is not expected to impact Cigna’s 2025 adjusted EPS guidance of at least $29.60.
Shields partners with over 80 health systems and 1,000+ hospitals and clinics nationwide, helping them build and manage specialty pharmacies. Evernorth’s expanded relationship with Shields aims to strengthen care continuity across specialty healthcare settings and provide additional investment opportunities over time.
BLOOMFIELD, Conn., Sept. 2, 2025 — Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI), announced a $3.5 billion preferred stock investment in Shields Health Solutions, a leading specialty pharmacy management company.
The investment coincides with Shields’ transition to a private standalone company, following its acquisition by Sycamore Partners from Walgreens Boots Alliance, which closed on August 28, 2025.
Evernorth said the investment supports the growing market for specialty medicine and aligns with its strategy to enhance care for people with complex and chronic conditions. The deal is not expected to impact Cigna’s 2025 adjusted EPS guidance of at least $29.60.
Shields partners with over 80 health systems and 1,000+ hospitals and clinics nationwide, helping them build and manage specialty pharmacies. Evernorth’s expanded relationship with Shields aims to strengthen care continuity across specialty healthcare settings and provide additional investment opportunities over time.
